Statistics for AbCellera Biologics Inc (id:7592 ABCL)

Valuation metrics

Market cap

782.72M

Enterprise value

210.98M

Trailing P/E (ttm)

-5.41

Forward P/E

-4.02

PEG ratio

-4.02

Price/Sales (ttm)

23.75

Price/Book (mrq)

0.73

Enterprise Value/Revenue

6.40

Enterprise Value/EBITDA

-0.95

Overview

Shares outstanding

295.37M

Float

189.00M

Shares short

16.64M

% Held by insiders

0.28%

% Held by institutions

0.38%

Average volume (10 days)

3.40M

Average volume (90 days)

Price summary

52-Week low

2.34

52-Week high

6.06

52-Week change

-64.13%

Beta

0.35

50-Day moving average

2.68

200-Day moving average

3.50

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

100.00%

Operating margin

-1,439.42%

Operational effectiveness

Return on assets

-13.26%

Return on equity

-15.55%

Income statement

Revenue (ttm)

0.11

Revenue per share (ttm)

0.11

Quarterly revenue growth (yoy)

Gross profit (ttm)

38.02M

EBITDA

-222,243,008.00

Net income to common (ttm)

-175,796,992.00

Diluted EPS (ttm)

-0.61

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

643.14M

Total cash per share (mrq)

2.18

Total debt (mrq)

71.40M

Total Debt/Equity (mrq)

6.62

Current ratio (mrq)

933.60%

Book value per share (mrq)

3.65

Cash flow

Cash flow statement

-120,167,000.00

Levered free cash flow (LFCF)

-105,576,000.00